Biosynex S.A.
ALBIO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €0 | €18,420 | €26,382 | €78,809 |
| - Cash | €4,763 | €4,691 | €5,409 | €20,168 |
| + Debt | €62,046 | €62,457 | €63,033 | €65,598 |
| Enterprise Value | €57,283 | €76,186 | €84,006 | €124,239 |
| Revenue | €50,500 | €47,500 | €53,700 | €50,325 |
| % Growth | 6.3% | -11.5% | 6.7% | – |
| Gross Profit | -€300 | -€9,400 | -€10,600 | €25,661 |
| % Margin | -0.6% | -19.8% | -19.7% | 51% |
| EBITDA | -€1,000 | -€9,205 | -€1,254 | -€10,222 |
| % Margin | -2% | -19.4% | -2.3% | -20.3% |
| Net Income | -€48,600 | -€22,300 | -€21,000 | -€17,553 |
| % Margin | -96.2% | -46.9% | -39.1% | -34.9% |
| EPS Diluted | -3.75 | -1.72 | -1.93 | -1.54 |
| % Growth | -118% | 10.9% | -25.3% | – |
| Operating Cash Flow | – | €1,263 | -€11,384 | €463 |
| Capital Expenditures | – | -€2,772 | -€2,068 | -€7,575 |
| Free Cash Flow | – | -€1,509 | -€13,452 | -€7,112 |